Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)
Status:
Not yet recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if using avatrombopag in patients with
thrombocytopenia due to temozolomide treatment can safely improve a patient's platelet count
and allow the patient to complete the temozolomide treatment course as planned.